Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating pioglitazone hydrochloride in patients with stage I-IIIA non-small cell lung cancer was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection [Phase 1]
Phase 1 trial evaluating erlotinib hydrochloride for HIV-infected patients with metastatic or unresectable non-small cell lung cancer was te…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients. [Phase 2]
This Phase 2 study in the UK evaluated the incidence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1]
This document reports a Phase 1 trial evaluating celecoxib in patients with stage IIIB or stage IV non-small cell lung cancer. The trial sta…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [Phase 1]
Phase 1 study evaluating the combination of erlotinib hydrochloride and cetuximab in patients with advanced cancers including head and neck,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating RO4929097 with erlotinib hydrochloride in stage IV or recurrent non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Cabazitaxel in Relapsed and Metastatic NSCLC [Phase 2]
This Phase 2 clinical trial update reports completion of a cabazitaxel study in relapsed and metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the combination of bortezomib with gemcitabine and cisplatin in advanced or metastatic non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC [Phase 2]
A Phase 2 trial of docetaxel plus bevacizumab in elderly patients with stage IV non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib in combination with bevacizumab as second-line therapy for non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing first-line Bevacizumab (Avastin) plus Erlotinib for stage IIIB/IV or recurrent non-squamous non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial of a decitabine-genistein combination reports maximum tolerated dose determination and early signals of safety and efficacy …
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: DNA Chip Based Prognosis of Lung Cancer
Completed clinical trial evaluating a DNA chip-based prognosis method for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating surgery with gemcitabine, cisplatin, and radiation for stage II or III non-small cell lung cancer was terminated,…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial (S0536) evaluated the combination of cetuximab, paclitaxel, carboplatin, and bevacizumab in patients with advanc…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: MONET1-MOtesanib NSCLC Efficacy and Tolerability Study [Phase 3]
The MONET1-Motesanib NSCLC Phase 3 trial was terminated, with the update noting the status but not providing results.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial of bevacizumab and ixabepilone in advanced or metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer [Phase 2]
Update on a Phase 2 study of Apatinib in RET fusion-positive advanced non-small cell lung cancer; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the efficacy and safety of pyrotinib in patients with HER2-mutant advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating nimotuzumab in combination with docetaxel for advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia [Phase 2]
Phase II trial evaluating whether inositol can prevent lung cancer in current or former smokers with bronchial dysplasia; the study is compl…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen [Phase 2]
A Phase 2 randomized trial comparing Pfizer's PF-00299804 (dacomitinib) to erlotinib in advanced non-small cell lung cancer that progressed …
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer [Phase 1]
A Phase 1 dose-finding study of cabozantinib (XL184) in Japanese subjects with advanced cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the combination of tivantinib (ARQ-197) and erlotinib in locally advanced or metastatic EGFR mutation-positive non-…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients. [Phase 1]
This update notes the completion of a Phase 1 study evaluating an IDO peptide vaccination in patients with stage III-IV non-small cell lung …